Rapamycin Sirolimus , the chemical formula for rapamycin is C₅₁H₇₉NO₁₃, indicating it contains 51 carbon atoms, 79 hydrogen atoms, 1 nitrogen atom, and 13 oxygen atoms, with a molecular weight of approximately 914.19 g/mol. Molecular Weight: 914.187 g/mol  , also known as rapamycin & sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumour (PEComa). It has immunosuppressant function in human and is especially useful in preventing the rejection of kidney transplant. It is a mammalian target of rapamycin (mTOR) kinase inhibitor that reduce the sensitivity of T cells and B cells to interleukin-2 (IL-2), inhibiting their activity. This compound also has a use in cardiovascular drug-eluting stent technology to inhibit restenosis. A plaque, written in Portuguese, commemorating the discovery of sirolimus on Easter Island, near Rano Kau It is produced by the bacterium Streptomyces hygroscopicus and was isolated for the first time in 1972, from samples of Streptomyces hygroscopicus found on Easter Island. The compound was originally named rapamycin after the native name of the island, Rapa Nui. Sirolimus was initially developed as an antifungal agent. However, this use was abandoned when it was discovered to have potent immunosuppressive and antiproliferative property due to its ability to inhibit mTOR. It was approved by the US Food and Drug Administration (FDA) in 1999. Hyftor (sirolimus gel) was authorized for topical treatment of facial angiofibroma in the European Union in May 2023. Medical use In the US, sirolimus, as Rapamune, is indicated for the prevention of organ transplant rejection & for the treatment of lymphangioleiomyomatosis; and, as Fyarro, in the form of protein-bound particles, for the treatment of adult with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumour (PEComa). In the EU, sirolimus, as Rapamune, is indicated for the prophylaxis of organ rejection in adult at low to moderate immunological risk receiving a renal transplant and for the treatment of people with sporadic lymphangioleiomyomatosis with moderate lung disease or declining lung function; and, as Hyftor, for the treatment of facial angiofibroma associated with tuberous sclerosis complex it is written in the Holy King James Bible the revelation of saint John the apostle 50 AD Anno Domini in the year of our Lord Jesus Christ Revelation 22:2 In the midst of the street of it, & on either side of the river, was there the tree of life, which bare twelve manner of fruits, & yielded her fruit every month: & the leaves of the tree were for the healing of the nations. amen “Let food be thy medicine, and let medicine be thy food.” Hippocrates 460BC Let supplements be thy medicine & let medicine be thy supplement let resveratrol be your supplement resveratrol expands life by 40%
https://www.youtube.com/watch?v=h0zMyrYbFZ8
Anti-Aging Enthusiasts are Taking this Pill to Extend Their Lives?
https://www.youtube.com/watch?v=qv7fClp-tGs
Longevity Secrets of Centenarians - Dr Nir Barzilai
https://www.youtube.com/watch?v=pufIY791O9I
Topical Rapamycin: How It Works